SCHOTT Pharma company profile
Company profile
SCHOTT Pharma has 5,002 employees and is headquartered in Mainz, Germany.
SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. The company offers syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPAC cosmetic, a polymer syringe for aesthetic treatments; SCHOTT TOPPAC freeze, a polymer syringe for deep-cold applications; SCHOTT TOPPAC sensitive, a polymer syringe for sensitive drugs; SCHOTT TOPPAC infuse, a polymer syringe for infusion therapy; SCHOTT TOPPAC unique, a polymer container; and SCHOTT TOPPAC cartridge. It also provides pharmaceutical glass cartridge, such as cartriQ for peptide and protein-based injectables; cartriQ Large Volume for large-volume injectables; Cartridges Double Chamber for lyophilized drugs; Cartridges Break Resistant; and TopLine and StandardLine cartridges and vials. In addition, the company offers pharmaceutical glass vial, including adaptiQ for injectables; EVERIC pure for unmatched drug stability; EVERIC freeze for deep-cold applications; EVERIC care for a pH range; EVERIC strong & smooth for the filling line performance; EVERIC smart; EVERIC plus for sensitive drug formulations; and EVERIC Iyo to avoid fogging for lyophilized drugs. Further, it provides pharmaceutical glass ampoule products, comprising Ampoules easyOPC for ampoule opening; Ampoules Anti-Counterfeiting for protection against drug counterfeiting; and StandardLine ampoules. It also provides containment and drug delivery, analytics, fill-and-finish, regulatory, and sustainability services. The company was founded in 1884 and is headquartered in Mainz, Germany. SCHOTT Pharma AG & Co. KGaA operates as a subsidiary of Schott Glaswerke Beteiligungs- Und Export Gmbh.
Company facts
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- Germany
- Headquarters
- Hattenbergstrasse 10, 55122, Mainz
- Employees
- 5,002
- Chief executive
- Christian Mias
- Founded
- 1884
- Fiscal year
- October - September
- Listing
- 1SXP · Xetra
- Currency
- EUR
- ISIN
- DE000A3ENQ51
- Website
- schott-pharma.com
SCHOTT Pharma and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| SCHOTT Pharma1SXP | Germany | $3.74B | 5,002 | 16.4% | 25.1 |
| Tecan GroupTECN | Switzerland | $3.58B | 3,000 | 4.9% | — |
| Fielmann GroupFIE | Germany | $3.93B | 18,213 | 13.7% | 16.4 |
| Carl Zeiss MeditecAFX | Germany | $3.07B | 5,784 | 7.2% | 23.3 |
| OttobockOBCK | Germany | $2.68B | 9,455 | 18.7% | 19.0 |
| AddLifeALIF.B | Sweden | $2.11B | 2,428 | 8.9% | 33.5 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.